Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sulphadiazine
- Therapeutic area
- Anti-infectives
- Drug class
- Other systemic antibacterials
- ATC
- J01
- Strength
- 1%
- Dosage form
- Cream
- Pack
- 50gm
- Registration no.
- 124110
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-10-10 03:32
Manufacturer
Solaris Life Sciences Private Limited,
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Silvezin 1% cream
Silvezin 1% cream contains Sulphadiazine 1%. It is registered with DRAP by Solaris Life Sciences Private Limited (registration no. 124110). Its official price is PKR 263.33 for a pack of 50gm. This price has applied since 23 July 2026. Silvezin is also available as 1 % cream. 5 other brands of Sulphadiazine 1% (cream) are registered in Pakistan. Compare all brands and prices →
Other strengths of Silvezin
Other brands of Sulphadiazine 1%
Official price over time
No change in the official DRAP price is recorded for this pack (50gm). Current price PKR 263.33, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Silvezin 1%, 50gm: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/silvezin-1-124110-50gm-solaris-life-sciences-private-limited/ (accessed 10 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 263.33 | 2026-07-23 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 124110Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
